Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Internal Medicine (Tokyo, Japan)|October 18, 2019
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal LiverNobuhiko Ogasawara, Satoshi Saitoh, Hideyuki Denpou, et al.
Liver Cancer|July 11, 2020
Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall PrognosisYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 26, 2024
Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapyYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary reportYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2020
Diagnosis and Resection Treatment of Triplet Hepatocellular Carcinomas with a non-B non-C Background in a Middle Aged Man over a Period of 6-yearsAkira Kajiwara, Keiichi Kinowaki, Norio Akuta, et al.
Internal Medicine (Tokyo, Japan)|May 8, 2024
Long-term Favorable Efficacy of Regular and Repeated Hospitalizations with a Personalized Diet and Exercise Treatment for Steatotic Liver DiseaseNorio Akuta, Yusuke Kawamura, Hitomi Sezaki, et al.
Hepatology International|July 24, 2015
Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitisYusuke Kawamura, Satoshi Saitoh, Yasuji Arase, et al.
Oncology|June 17, 2021
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib TreatmentYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Clinical Journal of Gastroenterology|July 12, 2020
Undifferentiated carcinoma of the liver demonstrated by contrast-enhanced ultrasonographyNobuhiko Ogasawara, Satoshi Saitoh, Fumitaka Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 9, 2023
Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictorsNorio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.
Pageof 30